Considering how little they needed, and what they need it for, I think the price they paid was too high. Here's my thinking:

A rights offering would have cost them much less, and only pushed back the "woo-ing" of US institutional investors for sometime in 2017. So what?

If we all had cashed them up now, and we get to see Denselight revenue ramp up over the next 12 months as they finish the main attraction (the integrated optical platform), wouldn't that put the company in a position of strength from which to roll out the marketing to US institutions (sometime in 2017)?

I mean, I actually don't understand where the fireworks are supposed to come from over the next 3-6 months. Suresh's letter tells me that they needed to pivot because the integrated optical platform is taking more time. I can accept that, but its hardly an assurance of some blockbuster news forthcoming that is going to get US institutions excited nearterm.

I feel like I have a better picture of what is not coming.

I'm not selling, but I am not buying either.